These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7545906)

  • 1. The effect of phosphorylation on the antigenic reactivity of p53 in cultured human keratinocytes.
    Kumar M; Spandau DF
    Biochem Biophys Res Commun; 1995 Sep; 214(2):744-53. PubMed ID: 7545906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-binding proteins in squamous cell carcinoma and normal human keratinocytes.
    Kumar MG; Spandau DF
    Cell Growth Differ; 1995 Dec; 6(12):1601-8. PubMed ID: 9019165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct conformations of p53 are observed at different stages of keratinocyte differentiation.
    Spandau DF
    Oncogene; 1994 Jul; 9(7):1861-8. PubMed ID: 7516060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Fujiki H
    Cancer Res; 1993 Jan; 53(2):239-41. PubMed ID: 8417815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
    Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
    Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.
    Zhang W; McClain C; Gau JP; Guo XY; Deisseroth AB
    Cancer Res; 1994 Aug; 54(16):4448-53. PubMed ID: 8044794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53.
    Chouinard N; Valerie K; Rouabhia M; Huot J
    Biochem J; 2002 Jul; 365(Pt 1):133-45. PubMed ID: 12071847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Okadaic acid inhibits dephosphorylation of cytoplasmic p53 during lymphocyte activation.
    McClure JE; Noonan CA; Shearer WT
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1578-84. PubMed ID: 8280176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Yuspa SH; Fujiki H
    Cancer Res; 1993 Mar; 53(5):992-6. PubMed ID: 7679949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.
    Dohoney KM; Guillerm C; Whiteford C; Elbi C; Lambert PF; Hager GL; Brady JN
    Oncogene; 2004 Jan; 23(1):49-57. PubMed ID: 14712210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope analysis of the human p53 tumour suppressor protein.
    Dolezalová H; Vojtĕsek B; Kovarík J
    Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs.
    Hecker D; Page G; Lohrum M; Weiland S; Scheidtmann KH
    Oncogene; 1996 Mar; 12(5):953-61. PubMed ID: 8649812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis by in vitro mutagenesis of PP2A alpha okadaic acid responsive sequences.
    Kaneko S; Shima H; Amagasa T; Takagi M; Sugimura T; Nagao M
    Biochem Biophys Res Commun; 1995 Sep; 214(2):518-23. PubMed ID: 7677760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphorylation in p53 acetylation and PAb421 epitope recognition in baculoviral and mammalian expressed proteins.
    Warnock LJ; Raines SA; Mee TR; Milner J
    FEBS J; 2005 Apr; 272(7):1669-75. PubMed ID: 15794754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification.
    Jardine LJ; Milne DM; Dumaz N; Meek DW
    Oncogene; 1999 Dec; 18(52):7602-7. PubMed ID: 10602521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.
    Legros Y; Lafon C; Soussi T
    Oncogene; 1994 Jul; 9(7):2071-6. PubMed ID: 8208553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of ErbB2 by 2-methyl-1,4-naphthoquinone (menadione) in human keratinocytes: role of EGFR and protein tyrosine phosphatases.
    Beier JI; von Montfort C; Sies H; Klotz LO
    FEBS Lett; 2006 Mar; 580(7):1859-64. PubMed ID: 16516204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
    Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
    Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anti-p53 antibodies in immunoblotting.
    Turpeinen M; Serpi R; Rahkolin M; Vähäkangas K
    Biochem Biophys Res Commun; 2002 May; 293(2):850-6. PubMed ID: 12054549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.